<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Max-Planck-Institute-Biology-Ageing on Bioecon</title><link>https://en.bioecon.ru/companies/max-planck-institute-biology-ageing/</link><description>Recent content in Max-Planck-Institute-Biology-Ageing on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Fri, 03 Jul 2026 17:28:31 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/max-planck-institute-biology-ageing/index.xml" rel="self" type="application/rss+xml"/><item><title>Geroscience &amp; senolytics</title><link>https://en.bioecon.ru/technology/geroscience-senolytics/</link><pubDate>Fri, 03 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/geroscience-senolytics/</guid><description>Selectively clearing senescent &amp;lsquo;zombie&amp;rsquo; cells or suppressing their inflammatory secretome to treat age-related disease at its molecular root, rather than one downstream condition at a time.</description></item></channel></rss>